FAH Highlights Price Transparency Compliance and Benefits of Hospital Integration in Statement to E&C Subcommittee 

FAH submitted a statement for the record in response to the House Energy and Commerce Health Subcommittee’s hearing today on several health care issues. The letter stated, “FAH and our member hospitals share the Subcommittee’s […]

Read More… from FAH Highlights Price Transparency Compliance and Benefits of Hospital Integration in Statement to E&C Subcommittee 

Cooperation is key to achieving price transparency, helping patients understand costs

Hospitals are working very hard to ease the anxiety that comes with medical bills by making sure patients understand their out-of-pocket costs before getting care. We believe that everyone deserves transparent, easy to understand information […]

Read More… from Cooperation is key to achieving price transparency, helping patients understand costs

FAH Comments on CY 2022 Medicare OPPS Proposed Rule

In comments submitted today, FAH reiterated its full support for CMS’s prospective budget-neutral 340B payment policy to continue to pay Average Sales Price (ASP) minus 22.5 percent for 340B-acquired drugs. “We agree with CMS that […]

Read More… from FAH Comments on CY 2022 Medicare OPPS Proposed Rule